Αποτελέσματα Αναζήτησης
1 Σεπ 2024 · Asundexian, an activated factor XI (XIa) inhibitor, is an oral anticoagulant that may prevent strokes with less bleeding. Methods. In a phase 3, international, double-blind trial, we randomly...
24 Μαΐ 2023 · Anticoagulation with direct oral anticoagulants (DOACs) reduces the risk of ischemic stroke and systemic embolism among persons with atrial fibrillation. 1 However, whether the timing...
30 Νοε 2023 · In addition, new recommendations addressing atrial fibrillation and thromboembolic risk assessment, anticoagulation, left atrial appendage occlusion, atrial fibrillation catheter or surgical ablation, and risk factor modification and atrial fibrillation prevention have been developed.
13 Σεπ 2024 · Most patients with atrial fibrillation (AF) should receive long-term oral anticoagulation to decrease the risk of ischemic stroke and other embolic events. For most patients, the benefit from anticoagulation outweighs the associated increase in the risk of bleeding.
8 Νοε 2023 · New late-breaking science from AHA 2023 sheds light on new treatments for patients with atrial fibrillation (AFib). In ARTESIA, the results of which were also published in the New England Journal of Medicine, patients with subclinical AFib who were treated with apixaban (5 mg/twice daily) were 37% less likely to have a stroke or systemic ...
30 Νοε 2023 · In patients with AF who are candidates for anticoagulation and without an indication for antiplatelet therapy, aspirin either alone or in combination with clopidogrel as an alternative to anticoagulation is not recommended to reduce stroke risk.
